spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  heart attack 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 15 Jan 2026
Boston Scientific announces agreement to acquire Penumbra, Inc.
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 25 Nov 2025
Medicare Finalizes Reimbursement for Caristo's CaRi-Plaque(TM) Across Hospital and Office Settings
Diagnostics Cardiology Reimbursement
 HSMN NewsFeed - 24 Sep 2025
TSC Life Receives FDA 510(K) Clearance for Fluido(R) AirGuard System, a Moderate to High Flow Blood and IV Fluid Warming Solution for the Prevention of Hypothermia
Devices FDA
 HSMN NewsFeed - 21 Aug 2025
FDA Clearance of Salix(R) Coronary Plaque Module
Devices Cardiology FDA
 HSMN NewsFeed - 20 Aug 2025
CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR
Devices FDA
 HSMN NewsFeed - 26 Mar 2025
Supira Medical Secures $120M Oversubscribed Series E Financing and Completes Enrollment of SUPPORT I Early Feasibility Study in the United States
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 3 Mar 2025
Boston Scientific Announces Agreement to Acquire SoniVie Ltd.
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 25 Sep 2024
Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF(R) Vial Access Needle ("VAN")
Devices Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 4 Sep 2024
Vesalio launches pVasc Thrombectomy System in the U.S. for peripheral occlusions
Devices Interventional Product Launch
 HSMN NewsFeed - 1 Mar 2024
Boston Scientific Receives FDA Approval for the AGENT(TM) Drug-Coated Balloon
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 27 Sep 2023
Implicity Expands Senior Leadership Team with New U.S. Chief Commercial Officer
Devices Cardiology Monitoring Personnel
 HSMN NewsFeed - 27 Jul 2023
FDA Grants Clearance for UltraSight's AI-Powered Cardiac Ultrasound Technology
Devices Cardiology Radiology FDA
 HSMN NewsFeed - 9 Jan 2023
SoniVie Raises $60m in Round C Financing, and Appoints New Board Members
Devices Venture Capital
 HSMN NewsFeed - 16 Sep 2022
Supira Medical Announces Successful First-In-Human Use Of Its Next Generation Percutaneous Ventricular Assist Device
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Jul 2022
SoniVie Announces successful procedure with TIVUS system on first patient enrolled for REDUCED1 Pilot study
Devices
 HSMN NewsFeed - 29 Jun 2022
EYLEA(R) (aflibercept) Injection sBLA for Every 16-week Dosing Regimen in Patients with Diabetic Retinopathy Accepted for FDA Review
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 May 2022
EuroPCR: Medtronic renal denervation system shows better blood pressure control with significantly more time in target range
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2022
Medtronic receives FDA approval for latest generation drug-eluting coronary stent system
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 28 Mar 2022
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi(R) (solriamfetol) to Axsome Therapeutics
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 28 Feb 2022
Supira Medical, a Shifamed Portfolio Company, Closes $30M in an Oversubscribed Series C Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 10 Sep 2021
CytoSorbents Announces Filing of an Investigational Device Exemption (IDE) for the U.S. Clinical Trial on Apixaban and Rivaroxaban Removal by the DrugSorb-ATR(TM) Antithrombotic Removal System During Urgent Cardiothoracic Surgery
Devices Surgery FDA
 HSMN NewsFeed - 12 Aug 2021
Second U.S. FDA Breakthrough Device Designation Granted to CytoSorbents' DrugSorb-ATR(TM) Antithrombotic Removal System Adding the Removal of Market-Leading Direct Oral Anticoagulants During Urgent Cardiothoracic Surgery
Devices FDA
 HSMN NewsFeed - 21 Jul 2021
Corium Launches Innovative ADHD Treatment AZSTARYS(TM) (serdexmethylphenidate and dexmethylphenidate) in the U.S. for Patients Age 6 Years and Older
Biopharmaceutical Neurology Product Launch
 HSMN NewsFeed - 1 Jul 2021
Heron Therapeutics Announces U.S. Commercial Launch and Availability of ZYNRELEF(TM) for the Management of Postoperative Pain for up to 72 Hours
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 30 Jun 2021
Abbott's XIENCE Stent Receives FDA Approval for Shortest Blood Thinner Course for High Bleeding Risk Patients
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 3 Jun 2021
Medtronic to Stop Distribution and Sale of HVAD(TM) System
Devices Cardiology Distribution
 HSMN NewsFeed - 13 May 2021
Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF(TM) (HTX-011) for the Management of Postoperative Pain for up to 72 Hours
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Dec 2020
Novartis announces FDA approval of Xolair(R) (omalizumab) for adults with nasal polyps
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Nov 2020
OMRON Strengthens Engagement with AliveCor with Series E Investment, Reinforces Cross-company Alliance for Remote Cardiovascular Condition Management
Devices Cardiology Monitoring Venture Capital
 HSMN NewsFeed - 6 May 2020
FDA Clears New Mechanical Thrombectomy Platform
Devices Interventional FDA
 HSMN NewsFeed - 29 Jan 2020
CytoSorb(R) is Approved and Available for the Removal of Ticagrelor, a Leading Anti-Platelet Drug, During Cardiopulmonary Bypass in the E.U.
Devices Regulatory Product Launch
 HSMN NewsFeed - 7 Jan 2020
HeartBeam Appoints Rich Ferrari and Marga Ortigas-Wedekind to its Board of Directors
Devices Cardiology Diagnostics Personnel
 HSMN NewsFeed - 2 Jan 2020
Amgen Commences Strategic Collaboration With BeiGene to Expand Oncology Presence in China
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 17 Dec 2019
Prasco launches NuvaRing(R) (etonogestrel/ethinyl estradiol vaginal ring) Authorized Generic in the United States
Biopharmaceuticals Generics Drug Delivery Product Launch
 HSMN NewsFeed - 1 Nov 2019
CytoSorbents Enrolls First Patient in TISORB Trial and Opens Operating Subsidiary in the United Kingdom
Devices
 HSMN NewsFeed - 24 Oct 2019
Amgen To Make Repatha(R) (evolocumab) Available Exclusively At Its Lower List Price Option In 2020
Biopharmaceuticals Cardiology Reimbursement
 HSMN NewsFeed - 10 Oct 2019
FDA Grants Ofev(R) Breakthrough Therapy Designation for Chronic Fibrosing ILDs with a Progressive Phenotype
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Oct 2019
Upsher-Smith Laboratories Launches Tosymra(TM) (sumatriptan) Nasal Spray For The Acute Treatment Of Migraine In Adults
Biopharmaceuticals Neurology Drug Delivery Product Launch
 HSMN NewsFeed - 27 Aug 2019
EBR Systems Closes $30M in New Funding, John McCutcheon Joins Company as President and CEO
Devices Cardiology Venture Capital Personnel
 HSMN NewsFeed - 6 Aug 2019
BioVentrix Announces Key Additions to Leadership Team
Devices Cardiology Personnel
 HSMN NewsFeed - 23 Jul 2019
Ortho Receives CE Mark for Enhanced VITROS(R) Immunodiagnostic Products NT-proBNP II Assay, an Aid in Diagnosing and Assessing Heart Failure
Diagnostics Cardiology Regulatory
 HSMN NewsFeed - 29 Apr 2019
New Study Finds Abbott Blood Test Can Help Predict Future Cardiac Events in Adults with No Known Heart Disease
Diagnostics Cardiology
 HSMN NewsFeed - 27 Mar 2019
Novartis receives FDA approval for Mayzent(R) (siponimod), the first oral drug to treat secondary progressive MS with active disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 21 Mar 2019
RegeneRx Announces New Board Member
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Mar 2019
Boehringer Ingelheim announces FDA and EMA regulatory submission for nintedanib in systemic sclerosis associated ILD
Biopharmaceuticals FDA Regulatory
 HSMN NewsFeed - 11 Mar 2019
Eisai and Imbrium Therapeutics Announce U.S. FDA Filing Acceptance of New Drug Application for Lemborexant for the Treatment of Insomnia
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Feb 2019
CHMP Recommends Approval of Praluent(R) (alirocumab) Injection to Reduce Cardiovascular Risk in People with Established Atherosclerotic Cardiovascular Disease
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 20 Dec 2018
HeartGuide, the highly-anticipated first wearable blood pressure monitor from Omron, available for pre-order on December 20th
Devices Monitoring Product Launch
 HSMN NewsFeed - 30 Oct 2018
G3 Pharmaceuticals Signs Exclusive License and Option Agreement for Treating Diastolic Heart Failure (HFpEF) by Inhibiting Galectin-3
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 30 Oct 2018
U.S. FDA Approves INVOKANA(R) (canagliflozin) to Reduce the Risk of Heart Attack, Stroke or Cardiovascular Death in Adults with Type 2 Diabetes and Established Cardiovascular Disease
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 23 Oct 2018
Duchesnay Inc. Announces Submission of Supplemental New Drug Application (sNDA) for Osphena(R) (ospemifene) to U.S. FDA Seeking Approval for the Treatment of Vaginal Dryness, a Symptom of Vulvar and Vaginal Atrophy (VVA) Due to Menopause
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Sep 2018
Aronora's New Blood Clot Treatment Receives FDA Fast Track Designation
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Sep 2018
Livongo Announces First Cellular-Enabled Blood Pressure Monitoring System in U.S.
Devices Cardiology Product Launch
 HSMN NewsFeed - 12 Sep 2018
FDA to Review Supplemental Biologics License Application for Praluent(R) (alirocumab)Injection as Potential Treatment to Reduce Major Adverse Cardiovascular Events
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 3 Sep 2018
Cablivi(TM) (caplacizumab) approved in Europe for adults with acquired thrombotic thrombocytopenic purpura (aTTP)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Aug 2018
Prevencio Announces Data Demonstrating HART PAD(TM) Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patients
Diagnostics Cardiology
 HSMN NewsFeed - 27 Aug 2018
Janssen Announces Results from MARINER and COMMANDER HF Studies
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 13 Aug 2018
Regeneron Provides Regulatory Update on EYLEA(R) (aflibercept) Injection sBLA in Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 6 Aug 2018
US WorldMeds and Salix Announce U.S. Launch of LUCEMYRA(TM) (lofexidine) 0.18 Mg Tablets
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 23 Jul 2018
MEDICALgorithmics, Medi-Lynx Receive FDA 510(K) Clearance for PocketECG CRS Mobile Cardiac Rehabilitation System
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 27 Jun 2018
Beckman Coulter Diagnostics Receives U.S. FDA 510(k) Clearance for High- sensitivity Access hsTnI Assay
Diagnostics Cardiology FDA
 HSMN NewsFeed - 30 May 2018
FDA expedites review of Novartis drug Promacta(R) for first-line severe aplastic anemia (SAA)
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 May 2018
Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 23 May 2018
ReCor Medical Announces RADIANCE-HTN SOLO Hypertension Study Meets Primary Efficacy Endpoint, Pivotal Study Submission, and New Principal Investigator
Devices Cardiology
 HSMN NewsFeed - 22 May 2018
Five-Year Study Data Confirm Positive Outcomes for Patients When Abbott Diagnostic Tool Was Used to Guide Heart Stenting Decisions
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Apr 2018
Surmodics Announces FDA Clearance of a New .018” Low-Profile PTA Balloon Dilation Catheter
Devices Interventional FDA
 HSMN NewsFeed - 9 Apr 2018
RegeneRx Announces Outcome of FDA Discussions for Development of RGN-259 for Dry Eye Syndrome
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 30 Mar 2018
Abiomed to Appoint New Chief Financial Officer Todd A. Trapp
Devices Cardiology Personnel
 HSMN NewsFeed - 26 Mar 2018
FDA approves inclusion of data from safety outcomes trial in the Tresiba(R) label
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 23 Mar 2018
Amgen Receives Positive CHMP Opinion Recognizing That Repatha(R) (evolocumab) Prevents Heart Attacks And Strokes
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 19 Mar 2018
EYLEA(R) (aflibercept) Injection Demonstrates Positive Topline Results in Phase 3 Non-Proliferative Diabetic Retinopathy Trial
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 27 Feb 2018
Abbott and Surmodics Announce Agreement for Next-Generation Drug-Coated Balloon
Devices Interventional Licensing
 HSMN NewsFeed - 14 Feb 2018
Phase II Data Support Potential for Novel Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody, RG7716, for People With Diabetic Macular Edema
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 13 Feb 2018
Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
Devices Cardiology FDA
 HSMN NewsFeed - 4 Jan 2018
Novartis drug Promacta(R) receives FDA Breakthrough Therapy designation for first-line use in severe aplastic anemia (SAA)
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Dec 2017
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 11 Dec 2017
Regeneron Announces FDA Acceptance of sBLA Filing for 12-Week Dosing of EYLEA(R) (aflibercept) Injection for Patients with Wet AMD
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 27 Nov 2017
Regeneron Provides Update on EYLEA(R) (aflibercept) Injection and Nesvacumab (Ang2 Antibody) Combination Program
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 13 Nov 2017
PlaqueTec Announces the Appointment of Annalisa Jenkins, MBBS, FRCP, as Chief Executive Officer
Devices Diagnostics Cardiology Personnel
 HSMN NewsFeed - 30 Oct 2017
FDA Approves New 10 mg Dosing for XARELTO(R) (rivaroxaban) to Reduce the Continued Risk of Venous Thromboembolism (VTE)
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Oct 2017
Abbott Introduces Next Generation of Most Widely Used Heart Stent for People with Coronary Artery Disease in Europe[1]
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 31 Aug 2017
RegeneRx Completes License Expansion for RGN-137 in Europe, S. Korea, Japan, Canada and Australia
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 28 Aug 2017
Philips and HeartFlow Announce Global Collaboration Agreement
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Aug 2017
HeartSciences Announces CE Mark and European Launch of MyoVista(R) High Sensitivity ECG Device
Devices Diagnostics Cardiology Regulatory Product Launch
 HSMN NewsFeed - 17 Aug 2017
BlueRock Therapeutics Expands Toronto Presence with R&D and Manufacturing Hub, Appoints Key R&D Leadership
Regenerative Medicine Personnel
 HSMN NewsFeed - 28 Jul 2017
FDA Grants Priority Review For Amgen's Supplemental Biologics License Application For Repatha(R) (evolocumab) To Include Data On Reducing Risk Of Cardiovascular Events
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 6 Jun 2017
100,000th Robotic-Arm Assisted Joint Replacement Procedure Performed in the U.S. with Stryker's Mako System
Devices Orthopaedic
 HSMN NewsFeed - 12 May 2017
Capricor Therapeutics Provides Update on ALLSTAR Trial
Regenerative Medicine Cardiology
 HSMN NewsFeed - 28 Apr 2017
FDA Approves Radius Health’s TYMLOS(TM) (abaloparatide), a Bone Building Agent for the Treatment of Postmenopausal Women with Osteoporosis at High Risk for Fracture
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Mar 2017
Landmark Outcomes Study Shows that Repatha(R) (evolocumab) Decreases LDL-C to Unprecedented Low Levels and Reduces Risk of Cardiovascular Events with No New Safety Issues
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 17 Mar 2017
New Study Shows Prevencio’s Simple Blood Test Determines Risk of Heart Attack, Stroke, or Cardiovascular Death
Diagnostics Cardiology
 HSMN NewsFeed - 9 Mar 2017
New Study Finds Abiomed Impella(R) Heart Pump Reduces Injury to Kidneys During High-Risk Percutaneous Coronary Intervention
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Feb 2017
Capricor Therapeutics Provides Update on Natriuretic Peptide Program
Biopharmaceuticals
 HSMN NewsFeed - 13 Feb 2017
NICE Guidance Recommends HeartFlow FFRct Analysis to Help Determine Cause of Stable Chest Pain in Patients
Devices Diagnostics Cardiology
 HSMN NewsFeed - 12 Dec 2016
Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 5 Dec 2016
Novelion Therapeutics Subsidiary, Aegerion Pharmaceuticals, Enters Into Licensing Agreement With Amryt Pharma for LOJUXTA(R) (lomitapide)
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 17 Nov 2016
Regeneron and Sanofi Announce Praluent(R) (alirocumab) Cardiovascular Outcomes Trial Will Continue as Planned Following Interim Analysis
Biopharmaceuticals
 HSMN NewsFeed - 1 Nov 2016
Pfizer Discontinues Global Development of Bococizumab, Its Investigational PCSK9 Inhibitor
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 27 Oct 2016
Heart Test Labs Appoints Industry Veteran Brian Allen as it Prepares for Commercial Launch of its MyoVista Medical Device
Devices Cardiology Product Launch Personnel
 HSMN NewsFeed - 25 Oct 2016
Miracor Receives Additional Funding in Series-C Closing to Expand Clinical and Commercial Activities with the PiCSO(R) Impulse System
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 24 Oct 2016
Efficacy of Ofev(R) (nintedanib) Reinforced in Range of Patients with IPF in New Analyses Presented at CHEST
Biopharmaceuticals
 HSMN NewsFeed - 20 Oct 2016
Akesys Medical and Elixir Medical Announce First Human Implant of the PRAVA(TM) Bioresorbable Scaffold for Peripheral Vascular Disease
Devices Interventional
 HSMN NewsFeed - 11 Oct 2016
FDA Grants Priority Review to Genentech’s Lucentis(R) (Ranibizumab Injection) Supplemental Biologics License Application for Myopic Choroidal Neovascularization
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 10 Oct 2016
St. Jude Medical Announces FDA Clearance and Launch of the New PressureWire X Guidewire Designed to Optimize PCI Procedures in Patients With Complex Anatomies
Devices Interventional Cardiology FDA Product Launch
 HSMN NewsFeed - 21 Sep 2016
U.S. FDA Approves INVOKAMET(R) XR (Canagliflozin / Metformin Hydrochloride Extended-Release) for the Treatment of Adults with Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 29 Jun 2016
FDA Advisory Committee recommends approval of Jardiance(R) (empagliflozin) for cardiovascular indication in 12-11 vote
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 18 May 2016
St. Jude Medical Announces European Launch of the Latest in PressureWire Guidewire Technology to Measure Pressure Differences Across Narrowed Coronary Arteries
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 16 May 2016
Neos Therapeutics Announces U.S. Launch of Adzenys XR-ODT(TM) (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients Six Years and Older
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 16 Mar 2016
Abbott's Absorb(TM), the First Fully Dissolving Heart Stent, Earns Positive Review by FDA Advisory Committee
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 15 Mar 2016
Orexigen and Takeda Jointly Announce Orexigen's Acquisition of All Rights to CONTRAVE(R) in the United States
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 8 Feb 2016
Angel Medical Systems Announces FDA Advisory Committee Meeting for Review of the AngelMed Guardian(R) System
Devices Cardiology Monitoring FDA
 HSMN NewsFeed - 29 Jan 2016
RegeneRx Announces Completion of Patient Enrollment In Phase 2b/3 U.S. Dry Eye Trial
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 18 Jan 2016
Michael Martino Named President and Chief Executive Officer of HemaFlo Therapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Nov 2015
Recardio Secures $3 Million in Series A Financing, Relocates Headquarters to San Francisco
Regenerative Medicine Cardiology Venture Capital
 HSMN NewsFeed - 5 Nov 2015
TherOx Receives FDA IDE Approval for Study of Next-Generation Supersaturated Oxygen Therapy for AMI
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 30 Oct 2015
Regeneron Announces EU Approval of EYLEA(R) (aflibercept) Injection for the Treatment of Visual Impairment Secondary to Myopic Choroidal Neovascularization
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 23 Oct 2015
Iroko Pharmaceuticals Receives FDA Approval for VIVLODEX(TM) - First Low Dose SoluMatrix(R) Meloxicam for Osteoarthritis Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Oct 2015
Silk Road Medical Announces up to $57 Million in New Funding for Novel Approach to Preventing Strokes
Devices Interventional Venture Capital
 HSMN NewsFeed - 12 Oct 2015
Abbott Announces Positive Clinical Results of Absorb(TM), the Naturally Dissolving Heart Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Oct 2015
Amicus Therapeutics Provides U.S. Regulatory Update for Migalastat Monotherapy
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Jul 2015
Regeneron and Sanofi Announce FDA Approval of Praluent(R) (alirocumab) Injection, the First PCSK9 Inhibitor in the U.S., for the Treatment of High LDL Cholesterol in Adult Patients
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 26 Jun 2015
EYLEA(R) (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 12 Jun 2015
FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Jun 2015
Amicus Therapeutics Submits Marketing Authorization Application (MAA) for Full Approval of Fabry Monotherapy Galafold(TM) (Migalastat) in European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 May 2015
Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 26 Feb 2015
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 23 Jan 2015
The Medicines Company Receives CHMP Positive Opinions for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(TM) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 8 Dec 2014
CardioKinetix Completes $50 Million Financing and Signs Agreement With Edwards Lifesciences, Including Exclusive Option to Purchase
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 28 Oct 2014
Hanson Medical Systems Becomes Preferred Distributor for PTS Diagnostics' CardioChek Family of Products
Diagnostics Distribution
 HSMN NewsFeed - 17 Oct 2014
EYLEA(R) (aflibercept) Injection Demonstrates Significantly Greater Gains in Visual Acuity than Both Bevacizumab and Ranibizumab in NIH-Sponsored Diabetic Macular Edema Study
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 22 Sep 2014
Regeneron Announces EYLEA(R) (aflibercept) Injection Approved for the Treatment of Patients with Myopic Choroidal Neovascularization (CNV) in Japan
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 11 Aug 2014
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 24 Jul 2014
Boston Scientific Receives CE Mark For Agent(TM) Drug-Coated Balloon
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 16 Jul 2014
First Patient Enrolment in MASCOT Registry Represents Major Milestone for COMBO(TM) Dual Therapy Stent and OrbusNeich's Clinical Programme
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Jun 2014
QT Vascular Announces FDA Clearance of Chocolate PTCA Balloon Catheter
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 2 Jun 2014
Toshiba’s Aquilion ONE Family Puts Customers First with the Industry’s Only Scalable Premium CT Solution
Devices Radiology Product Launch
 HSMN NewsFeed - 22 May 2014
Covidien Releases Two-Year Study Results Demonstrating Sustained Effectiveness of Drug-Coated Angioplasty Balloon Technology
Devices Interventional
 HSMN NewsFeed - 20 May 2014
STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 12 May 2014
FDA Approves ZONTIVITY(TM) (vorapaxar), First-in-Class PAR-1 Antagonist, for the Reduction of Thrombotic Cardiovascular Events in Patients with a History of Heart Attack or with Peripheral Arterial Disease
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 1 May 2014
FDA Approves Inspire(R) Upper Airway Stimulation (UAS) Therapy for Obstructive Sleep Apnea
Devices FDA
 HSMN NewsFeed - 1 May 2014
Boston Scientific Launches Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System In Japan
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Apr 2014
Jeffrey Gold Joins myoscience as President and Chief Operating Officer
Devices Personnel
 HSMN NewsFeed - 8 Apr 2014
Mitralign Completes Enrollment in EU Study for its Novel Catheter-based Valve Repair Device
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Mar 2014
Exelixis Receives Approval for COMETRIQ(R) (Cabozantinib) in the European Union for Treatment of Progressive, Unresectable Locally Advanced or Metastatic Medullary Thyroid Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 12 Mar 2014
Rosetta Genomics Provides Product Pipeline Update
Diagnostics
 HSMN NewsFeed - 6 Mar 2014
Boston Heart Enables Healthcare Providers to Better Identify Near-Term Risk of Heart Attack or Stroke with Launch of an Important Inflammation Marker, Myeloperoxidase (MPO)
Diagnostics Cardiology Product Launch
 HSMN NewsFeed - 3 Mar 2014
Genentech Provides Update on Phase III Study of Onartuzumab in People with Specific Type of Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Feb 2014
Cordis Corporation Receives CE Mark for RENLANE(TM) Renal Denervation System to Treat Resistant Hypertension
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 17 Feb 2014
Neurovive Pharmaceutical: NeuroVive Treats Final Patient in European Phase III Trial on CicloMulsion(R)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 5 Feb 2014
Boston Scientific Launches OffRoad(TM) Re-Entry Catheter System
Devices Interventional Product Launch
 HSMN NewsFeed - 13 Jan 2014
Galena Biopharma Acquires Mills Pharmaceuticals, LLC
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Jan 2014
STENTYS Expands Marketing of its Stents in Asia
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 18 Dec 2013
Medtronic Randomizes First Patients in SYMPLICITY HTN-4, the First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Dec 2013
Boston Scientific and The Medicines Company Announce U.S. Co-Promotion Agreement for Promus PREMIER(TM) Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Dec 2013
Medtronic Announces CE Mark and TGA Listing for the Symplicity Spyral(TM) Multi-Electrode Catheter and Symplicity G3(TM) Generator
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 2 Dec 2013
InspireMD Appoints Rick Olson as Vice President of Global Sales Operations
Devices Interventional Personnel
 HSMN NewsFeed - 4 Nov 2013
Supersaturated Oxygen Therapy IDE Study Results in Smaller Infarct Size for Next-Generation System
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Oct 2013
The Medicines Company's EUROMAX Trial of Angiox(R) (Bivalirudin) in Heart Attack Meets All Prespecified Endpoints
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 14 Oct 2013
CardioKinetix Announces First Heart Failure Patients Treated in China With Novel Minimally Invasive Structural Heart Device
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Oct 2013
Pfizer Inc. Announces FDA Approval of DUAVEE(TM) (conjugated estrogens/ bazedoxifene) for the Treatment of Moderate-to-Severe Vasomotor Symptoms (Hot Flashes) Associated with Menopause and the Prevention of Postmenopausal Osteoporosis [1]
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Sep 2013
Rochester General Health System Installs Masimo Patient SafetyNet(TM) for Advanced Care and Oversight of Patients
Devices Monitoring
 HSMN NewsFeed - 13 Sep 2013
Alexion's Soliris(R) (eculizumab) Receives Marketing Approval in Japan for All Patients with aHUS
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 4 Sep 2013
InspireMD Announces New Appointment to the Board of Directors
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 4 Sep 2013
New Data Suggests Abbott's High Sensitive Troponin Test May Help Doctors More Accurately Diagnose Heart Attacks in Women
Diagnostics Cardiology
 HSMN NewsFeed - 3 Sep 2013
Encision Announces Death of Chief Executive Officer Fred F. Perner
Devices Surgery Personnel
 HSMN NewsFeed - 29 Aug 2013
CardioKinetix Announces First Heart Failure Patients Treated in Asia with Minimally Invasive Structural Heart Device
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Aug 2013
St. Jude Medical Receives European Approval for New Renal Denervation System That Reduces Total Ablation Time by More Than 80 Percent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 22 Aug 2013
Horizon Pharma Announces Settlement of DUEXIS(R) Patent Litigation With Par Pharmaceutical
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 22 Aug 2013
Infraredx Receives $25 Million Investment from Nipro Corporation
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 13 Aug 2013
BioVentrix Expands Use of Its Revivent(TM) System for Heart Failure Treatment with First Clinical Procedure in Germany
Devices Cardiology
 HSMN NewsFeed - 31 Jul 2013
New Sub-Analysis of PLATO ACS Study Suggests Patient Types and Stent Types Had No Impact on Findings of Reduced Rate of Stent Thrombosis With BRILINTA (ticagrelor)
Biopharmaceuticals Devices Interventional Cardiology
 HSMN NewsFeed - 18 Jul 2013
First Robotic-Assisted Stent Placement in Acute Heart-Attack Patient Performed at Sanford Aberdeen Medical Center
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Jul 2013
Mother of Four with Congenital Heart Defect & Biventricular Heart Failure Bridged to Transplant with the SynCardia Total Artificial Heart
Devices Cardiology
 HSMN NewsFeed - 12 Jul 2013
Boston Scientific Launches Guidezilla(TM) Guide Extension Catheter in U.S. and Europe
Devices Interventional Cardiology FDA Product Launch
 HSMN NewsFeed - 10 Jul 2013
STENTYS Self-Apposing Stent Approved in Europe for Additional Coronary Indications
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 8 Jul 2013
Capricor and Nile Therapeutics Announce Merger Agreement
Regenerative Medicine Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 4 Jun 2013
St. Jude Medical Initiates First US Clinical Study of the EnligHTN Renal Denervation System for Drug-Resistant High Blood Pressure
Devices Cardiology Interventional
 HSMN NewsFeed - 23 May 2013
Six Month Data Reported for WAVE I Study of Renal Denervation Therapy for Hypertension at EuroPCR Meeting in Paris
Devices Cardiology
 HSMN NewsFeed - 23 May 2013
InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group
Devices Interventional Cardiology
 HSMN NewsFeed - 23 May 2013
One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology
Devices Cardiology
 HSMN NewsFeed - 22 May 2013
Boston Scientific Promus PREMIER(TM) and SYNERGY(TM) Drug-Eluting Stent Systems Provide Exceptional Safety and Efficacy Data
Devices Interventional Cardiology
 HSMN NewsFeed - 21 May 2013
Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 16 May 2013
InspireMD Announces Reimbursement Coverage for MGuard(TM) Coronary Embolic Protection Stent
Devices Interventional Cardiology Reimbursement
 HSMN NewsFeed - 14 May 2013
St. Jude Medical Announces First Patient Enrollment in EnligHTN III Renal Denervation Study of Next-Generation EnligHTN System
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Mar 2013
FDA Approves New Drug Application (NDA) for Teva’s Quartette(TM) (levonorgestrel/ethinyl estradiol and ethinyl estradiol) Tablets for the Prevention of Pregnancy
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Mar 2013
Capricor, Inc. Appoints Anthony Davies, Ph.D., Chief Technology Officer
Regenerative Medicine Cardiology Personnel
 HSMN NewsFeed - 7 Mar 2013
Symplicity(TM) Renal Denervation System One of First Devices Accepted to Participate in Concurrent Review for Joint FDA Premarket Approval and Medicare National Coverage Determination
Devices Interventional Cardiology Reimbursement FDA
 HSMN NewsFeed - 26 Feb 2013
DecImmune Therapeutics Secures $2.25 Million in Development Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Feb 2013
Intravase(R) Approval Opens Vascular Market for Cytori
Regenerative Medicine FDA
 HSMN NewsFeed - 14 Feb 2013
Miracor Granted Five Additional U.S. Patents and One Additional European Patent for Its PICSO(R) System to Treat Severe Heart Attack Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Feb 2013
Aviir Secures Second $10 Million Financing Tranche; Attracts New Investor Group
Diagnostics Cardiology Venture Capital
 HSMN NewsFeed - 11 Feb 2013
Cardiorentis initiates first-ever acute heart failure Phase III clinical trial designed to assess early treatment on cardiovascular mortality and symptoms
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 9 Jan 2013
Ischemix, Inc. Appoints New Chief Executive Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 9 Jan 2013
Velomedix Receives Health Canada Approval for VELOCITY Pilot Study and Bolsters Leadership Team
Devices Cardiology Regulatory
 HSMN NewsFeed - 4 Jan 2013
InspireMD Names Alan Milinazzo President and CEO
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 18 Dec 2012
St. Jude Medical Enrolls First Patient in ILUMIEN I Study to Develop Guidance for Stent Optimization
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Dec 2012
Angel Medical Systems, Inc. Completes Initial Closing of $27.5 Million Financing
Devices Cardiology Monitoring Venture Capital Personnel
 HSMN NewsFeed - 11 Dec 2012
BG Medicine Obtains CE Mark for CardioSCORE(TM) Test in Europe
Diagnostics Cardiology Regulatory
 HSMN NewsFeed - 4 Dec 2012
Clinical study results using Miracor’s PICSO(R) system show potential to treat severe heart attack (STEMI) patients and are published in December’s Journal of Interventional Cardiology
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Nov 2012
Trinity Medical Center Adds Masimo Patient SafetyNet(TM) as a High Vigilance Safeguard for Post-Surgical Patients
Devices Monitoring
 HSMN NewsFeed - 26 Oct 2012
Tengion Provides Patient Update on its Neo-Urinary Conduit(TM) Clinical Program
Devices Urology
 HSMN NewsFeed - 24 Oct 2012
CardioKinetix Announces Data From Latest European Study of Heart Failure Patients With First-of-Its-Kind Percutaneous Treatment
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2012
The Boston Scientific Epic(TM) Stent Continues to Demonstrate Positive Clinical Outcomes for Patients with Iliac Artery Disease
Devices Interventional
 HSMN NewsFeed - 23 Oct 2012
The Boston Scientific PROMUS Element(TM) Platinum Chromium Stent Demonstrates Positive Outcomes in Patients with Long Coronary Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2012
CardioKinetix Receives CE Mark Approval for Full Range of Sizes for First-of-Its-Kind Percutaneous Treatment for Heart Failure
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 22 Oct 2012
STENTYS Receives FDA Approval to Initiate First U.S. Clinical Trial With Self-Apposing(R) Stent
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 22 Oct 2012
STENTYS Self-Apposing(R) Stent Continues to Demonstrate Low Mortality at One Year in APPOSITION III Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Oct 2012
First Patient Treated in Cytori’s U.S. Cell Therapy Heart Failure Trial
Regenerative Medicine Cardiology
 HSMN NewsFeed - 28 Sep 2012
Boston Scientific Launches Emerge(TM) PTCA Balloon Dilatation Catheter in the U.S.
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 25 Sep 2012
Abbott Announces International Launch of the Absorb(TM) Bioresorbable Vascular Scaffold
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Sep 2012
Cialis(R) (tadalafil) Tablets Recommended for Approval for the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia in the European Union
Biopharmaceuticals Urology Regulatory
 HSMN NewsFeed - 11 Sep 2012
BG Announces Key Additions to Senior Management Team
Diagnostics Cardiology Personnel
 HSMN NewsFeed - 28 Aug 2012
Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 7 Aug 2012
Abbott's Omnilink Elite(R) Vascular Balloon-Expandable Stent System Receives FDA Approval for Treatment of Iliac Artery Disease
Devices Interventional FDA
 HSMN NewsFeed - 26 Jul 2012
Response Biomedical Corp. Announces New Hire, Mr. Tim Shannon, as Senior Vice President, World Wide Sales & Marketing
Diagnostics Personnel
 HSMN NewsFeed - 26 Jul 2012
FDA Advisory Committee Unanimously Recommends Approval of Lucentis for Treatment of Diabetic Macular Edema (DME)
Biopharmaceuticals Ophthalmology Endocrinology FDA
 HSMN NewsFeed - 24 Jul 2012
Transgenomic Announces Medicare Coverage for Clopidogrel (Plavix(R)) Response Test
Diagnostics Cardiology Reimbursement
 HSMN NewsFeed - 23 Jul 2012
Addition of Tarceva(R) (erlotinib) to Nexavar(R) (sorafenib) did not Provide Additional Benefit to Patients with Unresectable Liver Cancer Versus Nexavar alone in Phase 3 Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Jul 2012
St. Jude Medical Announces Japanese Launch of Industry's First Small Quadripolar Technology to Treat Heart Failure
Devices Cardiology
 HSMN NewsFeed - 9 Jul 2012
Capricor Announces FDA Approval To Initiate ALLSTAR Trial of Allogeneic Stem Cell Therapy In Patients Following Heart Attack
Regenerative Medicine Cardiology FDA
 HSMN NewsFeed - 2 Jul 2012
BG Medicine, Inc. Appoints Bill Densel, General Manager, CardioSCORE
Diagnostics Cardiology Personnel
 HSMN NewsFeed - 7 Jun 2012
CardioKinetix Initiates European Post-Market Trial of First-of-Its-Kind Minimally Invasive Treatment for Heart Failure in Germany
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Jun 2012
Study Confirms the Value of Cambridge Heart’s MTWA Test as a Predictor of Life-Threatening Cardiac Events
Devices Monitoring Cardiology
 HSMN NewsFeed - 30 May 2012
Kona Medical Secures $30M in Financing to Pursue Novel Hypertension Therapy
Devices Cardiology Venture Capital Personnel
 HSMN NewsFeed - 25 May 2012
Medtronic Resolute(R) Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes
Devices Interventional Cardiology Endocrinology
 HSMN NewsFeed - 18 May 2012
CardioKinetix Announces Positive Two-Year Clinical Data for First-of-Its-Kind Minimally Invasive Treatment for Heart Failure
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2012
STENTYS Self-Apposing(R) Stent shows very low mortality at one month in 1,000 high-risk heart attack patients
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2012
Boston Scientific Announces Positive Data From Lotus(TM) Transcatheter Aortic Valve Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 14 May 2012
STENTYS Expands Its Product Offerings for Treating Heart Attacks
Devices Interventional Cardiology
 HSMN NewsFeed - 9 May 2012
Janssen Research & Development Submits Supplemental New Drug Application to U.S. FDA for XARELTO(R) (rivaroxaban) to Reduce the Risk of Stent Thrombosis in Patients with Acute Coronary Syndrome
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 7 May 2012
CardioKinetix Announces Late Breaking EuroPCR Session Featuring First-of-Its-Kind Minimally Invasive Treatment for Heart Failure
Devices Interventional Cardiology
 HSMN NewsFeed - 7 May 2012
Maria Sainz Joins CardioKinetix as President and Chief Executive Officer
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 2 May 2012
EKOS Corporation Announces Two More Pulmonary Embolism Clinical Studies
Devices Drug Delivery
 HSMN NewsFeed - 1 May 2012
RF-TVA Therapy Offers Hope for Patients Suffering from Osteoporosis-Related Spine Fractures
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 27 Apr 2012
Trial of Medtronic Symplicity(TM) Renal Denervation System Shows Significant Blood Pressure Reduction, With No Evidence of Renal Impairment, at Six Months Post Treatment
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Apr 2012
Boston Scientific Announces CE Mark and European Launch of Emerge(TM) PTCA Dilatation Catheter
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 23 Apr 2012
Boston Scientific Completes Enrollment in Clinical Trial to Evaluate Lotus(TM) Aortic Valve System
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Apr 2012
Heart Failure Patients Demonstrate Impressive Improvement With Novel, Less Invasive Technique Using BioVentrix Therapy
Devices Cardiology
 HSMN NewsFeed - 11 Apr 2012
Takeda to Acquire URL Pharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Mar 2012
InterMune Appoints Mr. Jean-Jacques Bienaime and Dr. Frank Verwiel to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Mar 2012
VectraCor Receives FDA Approval for Real-Time Detection of ECG Changes Suggestive of AMI
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 23 Mar 2012
St. Jude Medical Announces Next-Generation PressureWire for FFR Measurement
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 19 Mar 2012
Cameron Health’s S-ICD(R) System Scheduled for FDA Panel Review on April 26, 2012
Devices Cardiology FDA
 HSMN NewsFeed - 7 Mar 2012
Abbott's Absolute Pro(R) Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease
Devices Interventional FDA
 HSMN NewsFeed - 1 Mar 2012
Allegheny General Hospital Implants Region's First SynCardia Total Artificial Heart
Devices Cardiology
 HSMN NewsFeed - 28 Feb 2012
Miracor receives $3.5 million cash infusion to begin pivotal clinical “RAMSES” trial of its PICSO system, designed to improve myocardial perfusion following primary PCI
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Feb 2012
Boston Scientific Receives Industry's First FDA Approval for Drug-Eluting Coronary Stent Use in Heart Attack Patients
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 22 Feb 2012
Vascular Magnetics Raises $7 Million in Series A Financing to Advance Magnetically Targeted Drug Delivery System for Peripheral Artery Disease
Devices Drug Delivery Venture Capital
 HSMN NewsFeed - 15 Feb 2012
Researchers Show TB4 Provides Both Neuroprotection and Neurorestoration after Traumatic Brain Injury
Biopharmaceuticals Neurology Regenerative Medicine
 HSMN NewsFeed - 14 Feb 2012
Miraculins Appoints Distinguished U.S. Cardiologist Dr. Henry Solomon to PreVu Medical Advisory Board
Diagnostics Cardiology Personnel
 HSMN NewsFeed - 14 Feb 2012
Bioheart Acquires Exclusive Rights to Ageless Regenerative Institute's Adipose Cell Technology
Regenerative Medicine Cardiology
 HSMN NewsFeed - 8 Feb 2012
Velomedix Closes New Financing, Strengthens Leadership Team
Devices Cardiology Neurology Venture Capital Personnel
 HSMN NewsFeed - 7 Feb 2012
New Study Evaluates Cialis(R) in parallel with Tamsulosin in Men with Signs and Symptoms Suggestive of Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 30 Jan 2012
CardioKinetix Receives Expanded CE Mark Approval for World's First Percutaneous Left Ventricular Partitioning Device, the Parachute(TM), for Treatment of Ischemic Heart Failure
Devices Cardiology Regulatory
 HSMN NewsFeed - 30 Jan 2012
Cytori Receives Approval From FDA to Initiate U.S. Cardiac Cell Therapy Trial; Investigational Device Exemption (IDE) Approved for ATHENA
Regenerative Medicine Cardiology
 HSMN NewsFeed - 25 Jan 2012
New FDA Approved Labeling For VYTORIN(R) (Ezetimibe/Simvastatin) Includes Results From the Study of Heart and Renal Protection (SHARP) in Patients With Moderate to Severe Chronic Kidney Disease
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 24 Jan 2012
Adipose Stem Cell Heart Attack Trial Data Published in Journal of the American College of Cardiology; Cytori's APOLLO Trial Demonstrated Safety & Feasibility and Improvements in Cardiac Function
Regenerative Medicine Cardiology
 HSMN NewsFeed - 20 Jan 2012
La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 18 Jan 2012
Independent Data Safety Monitoring Board Recommends St. Jude Medical’s FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis
Devices Cardiology
 HSMN NewsFeed - 16 Jan 2012
Boston Scientific Epic(TM) Stent Demonstrates Positive Clinical Outcomes in Orion Trial
Devices Interventional
 HSMN NewsFeed - 5 Jan 2012
First Patients in Portugal, Latvia, Slovenia, and the United Kingdom Treated With CardioKinetix's Parachute(TM) Ventricular Partitioning Device
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Dec 2011
Pfizer Elects CEO Ian Read As Chairman Of The Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Dec 2011
Abbott Initiates Clinical Trial to Evaluate the Absorb(TM) Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Nov 2011
Soliris(R) (eculizumab) Granted Marketing Authorization in Europe for Treatment of Patients with Atypical Hemolytic Uremic Syndrome (aHUS)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 7 Nov 2011
InfraReDx Announces the Launch of the TVC Imaging System(TM) for True Vessel Characterization of Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Nov 2011
Miracor to Report Successful Clinical Study Results of Its PICSO(R) System Designed to Improve Myocardial Perfusion Following Primary PCI
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Oct 2011
Sarah Schiltz Named VP of Marketing at Atherotech Diagnostics Lab
Diagnostics Personnel
 HSMN NewsFeed - 26 Oct 2011
St. Jude Medical Announces FDA Clearance of First and Only Combined FFR and OCT System
Devices Cardiology FDA
 HSMN NewsFeed - 7 Oct 2011
Cialis(R) for Once Daily Use Now FDA-Approved to Treat Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) and Men With Both Erectile Dysfunction (ED) and Signs and Symptoms of BPH
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Oct 2011
Ventus Medical Launches Provent(R) Sleep Apnea Therapy in Australia and New Zealand
Devices
 HSMN NewsFeed - 22 Sep 2011
Cambridge Heart Announces Agreement to Distribute Its HearTwave II System in Singapore
Devices Cardiology Distribution
 HSMN NewsFeed - 21 Sep 2011
STENTYS Completes Enrollment of APPOSITION III Study for its Self-Apposing Stent to Treat Heart Attacks
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Sep 2011
CardioKinetix Inc. Raises $44 Million in Series E Financing
Devices Cardiology Venture Capital Personnel
 HSMN NewsFeed - 14 Sep 2011
Toshiba’s Aquilion ONE Helps Diagnose Stroke and Cardiovascular Conditions Faster, More Accurately in the ED
Devices Radiology
 HSMN NewsFeed - 31 Aug 2011
St. Jude Medical Begins U.S. Trial Studying ST Segment Monitoring Technology
Devices Cardiology Monitoring
 HSMN NewsFeed - 26 Jul 2011
Diffusion Pharmaceuticals Receives FDA Orphan Status for TSC, a First-in-Class Drug for the Treatment of Primary Brain Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Jul 2011
NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications
Devices Interventional Licensing
 HSMN NewsFeed - 13 Jul 2011
InfraReDx Initiates a Randomized Clinical Trial of LipiScan IVUS™ Coronary Imaging Guidance to Prevent Heart Attacks During Stenting
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Jun 2011
Abbott Receives FDA Approval for a New Six-Month Formulation of Lupron Depot(R) (leuprolide acetate for depot suspension) for the Palliative Treatment of Advanced Prostate Cancer
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 13 Jun 2011
Pathway Medical Technologies Expands JETSTREAM G3 SF Family With FDA 510(k) Clearance for 1.6 mm Catheter
Devices Interventional FDA
 HSMN NewsFeed - 20 May 2011
Cost Effectiveness Study Determines FFR Can Improve Health while Reducing Economic Burden in UK, France and Italy
Devices Interventional Cardiology
 HSMN NewsFeed - 19 May 2011
Study Provides Insight on Medtronic CoreValve(R) System Implants Through Subclavian Approach
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Apr 2011
St. Jude Medical Sponsored Study Determines FFR Can Improve Health while Reducing Economic Burden to German Healthcare System
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Apr 2011
InfraReDx Receives European CE Mark Approval of LipiScan(TM) IVUS Coronary Imaging System
Devices Cardiology Regulatory
 HSMN NewsFeed - 7 Apr 2011
Alexion Submits Applications for Soliris(R) (Eculizumab) as a Treatment for Patients with Atypical Hemolytic Uremic Syndrome (aHUS) in the United States and European Union
Biopharmaceuticals
 HSMN NewsFeed - 4 Apr 2011
SCAI Statement on "The RIVAL Trial: A Randomized Comparison of Radial Versus Femoral Access for Coronary Angiography or Intervention in Patients With Acute Coronary Syndromes"
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Apr 2011
Data From Landmark Clinical Trial of Abbott's MitraClip(R) System Demonstrate Durable Clinical Benefits for Patients With Mitral Regurgitation Two Years After Treatment
Devices Cardiology
 HSMN NewsFeed - 29 Mar 2011
FDA Clears Abbott's i-STAT(R) 1 Wireless Point of Care Testing System
Devices Diagnostics FDA
 HSMN NewsFeed - 28 Mar 2011
Pathway Medical Technologies Announces Enrollment of First Patient in JETSTREAM G3 Calcium Study
Devices Interventional
 HSMN NewsFeed - 25 Mar 2011
Second Lucentis Phase III Study Meets Primary Endpoint for Improved Vision in Patients with Diabetic Macular Edema (DME)
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 21 Mar 2011
OrbusNeich Files Lawsuit Against Dr. Pavel Cervinka for Defamation
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 17 Mar 2011
STENTYS Expands Operations into Four Additional European Countries
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 9 Mar 2011
2011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery
Diagnostics Biopharmaceuticals Surgery Cardiology
 HSMN NewsFeed - 24 Feb 2011
FDA Grants Genentech a Hearing on Avastin’s Use for Metastatic Breast Cancer in the United States
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Feb 2011
Stereotaxis Announces First Worldwide Use of Remote Magnetic Navigation for Renal Ablation to Treat Hypertension
Devices Interventional
 HSMN NewsFeed - 14 Feb 2011
ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Feb 2011
Lucentis Phase III Study Meets Primary Endpoint for Improving Vision in Patients With Diabetic Macular Edema (DME)
Biopharmaceuticals Endocrinology Ophthalmology
 HSMN NewsFeed - 9 Feb 2011
InfraReDx Appoints Donald Southard as President and Chief Executive Officer
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 25 Jan 2011
Phase III Study for Eritoran Does Not Meet Primary Endpoint
Biopharmaceuticals
 HSMN NewsFeed - 17 Jan 2011
EKOS Corporation Receives CE Mark to Treat Massive and Sub-Massive Pulmonary Embolism
Devices Regulatory
 HSMN NewsFeed - 13 Jan 2011
Medtronic Completes Acquisition of Ardian
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 4 Jan 2011
Response Biomedical Corporation Enters Into Exclusive Italian Distribution Agreement with Cremascoli & Iris, s.r.l.
Diagnostics Distribution
 HSMN NewsFeed - 16 Dec 2010
Genentech Provides Update on Avastin for Metastatic Breast Cancer Following Reviews in Europe and the United States
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Dec 2010
Economic Evaluation of FAME Trial Confirms Using FFR in Treatment of Coronary Artery Disease Is Cost-Effective
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Dec 2010
STENTYS begins large-scale, "real life" study with its self-apposing stent for treatment of Heart Attacks
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Dec 2010
Abiomed Receives Conditional FDA Approval for Study with Impella 2.5 in Reducing Heart Muscle Damage Following PCI in STEMI Patients
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 22 Nov 2010
Medtronic Signs Agreement to Acquire Ardian
Devices Mergers & Acquisitions
 HSMN NewsFeed - 16 Nov 2010
Mortality Data Presented for Patients Treated with Effient(R) Who Underwent Isolated Coronary Artery Bypass Surgery
Biopharmaceuticals Cardiology Surgery
 HSMN NewsFeed - 16 Nov 2010
GRAVITAS Trial Shows That a Uniform Treatment Strategy of Doubling the Standard Dose of Plavix Does Not Improve Outcomes Post-PCI
Diagnostics Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 9 Nov 2010
Miracor reports successful first-in-man clinical outcome for its PICSO(R) system designed to improve acute coronary syndrome (ACS) revascularization following primary percutaneous coronary intervention (PCI)
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Oct 2010
APP Pharmaceuticals Announces Approval of Metoprolol Tartrate Injection, USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 26 Oct 2010
Response Biomedical Corporation Announces the Resignation of Chief Operating Officer
Diagnostics Personnel
 HSMN NewsFeed - 12 Oct 2010
InfraReDx Completes $21 Million Equity Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 30 Sep 2010
Abiomed Announces Specialized Partner Program for Heart Recovery in the Treatment of Emergent Cardiac Care Patients
Devices Cardiology
 HSMN NewsFeed - 28 Sep 2010
Medtronic's Insertable Cardiac Monitor Documented Arrhythmias in Post-Heart Attack Patients
Devices Monitoring Cardiology
 HSMN NewsFeed - 28 Sep 2010
Boston Scientific Welcomes Publication of Analysis Demonstrating Long-Term Survival Benefit for ICD Therapy
Devices Cardiology
 HSMN NewsFeed - 27 Sep 2010
DecImmune Therapeutics Secures $3.2 Million in Development Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Sep 2010
Takeda Responds to Announcement about Suspension of Rosiglitazone Marketing Authorization in Europe and Restrictions in the U.S.
Biopharmaceuticals Endocrinology Regulatory
 HSMN NewsFeed - 23 Sep 2010
Abbott's XIENCE V(R) Shows Continued Strong Performance in Key Safety and Efficacy Measures at Two Years in Investigator-Initiated COMPARE Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2010
Abbott's XIENCE V(R) Shows Outstanding Two-Year Clinical Results Versus TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2010
Portola Pharmaceuticals Appoints Jean-Jacques Bienaime to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Sep 2010
Angel Medical Systems Receives CE Mark Approval for the AngelMed Guardian, an Implantable Device Designed to Provide Early Warning of a Heart Attack
Devices Cardiology Regulatory
 HSMN NewsFeed - 22 Sep 2010
Stentys Self-Apposing Stent Proves Superior to Conventional Treatment of Acute Myocardial Infarction
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Sep 2010
PROMUS(R) Element Stent Approved for Use in Diabetic and Heart Attack Patients in CE Mark Countries
Devices Regulatory Interventional Cardiology
 HSMN NewsFeed - 21 Sep 2010
Cardiac Science Launches Cambridge Heart's Microvolt T-Wave Alternans (MTWA) Technology in Stress Test Systems
Devices Monitoring Cardiology
 HSMN NewsFeed - 13 Sep 2010
Response Biomedical Announces Strategic Realignment of Resources
Diagnostics
 HSMN NewsFeed - 1 Sep 2010
InfraReDx Receives FDA Clearance for LipiScan IVUS Coronary Imaging System
Devices Cardiology
 HSMN NewsFeed - 31 Aug 2010
New 2010 ESC Guidelines for Percutaneous Coronary Interventions Reinforce Importance of FFR in Treatment of Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Aug 2010
Novartis receives FDA approval of Tekamlo, a single-pill combination of aliskiren and amlodipine to treat high blood pressure
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 23 Aug 2010
Novo Nordisk Inc. Announces Exclusive Agreement With Upsher-Smith Laboratories, Inc. to Market Vagifem(R) 10 mcg
Biopharmaceuticals
 HSMN NewsFeed - 29 Jul 2010
FDA Advisory Committee Recommends US FDA Approval of Brilinta (Ticagrelor) for Acute Coronary Syndromes
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 26 Jul 2010
FDA Approves Tribenzor, A New Three-In-One Combination Product for the Treatment of High Blood Pressure
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Jul 2010
Tethys Raises $33 Million
Diagnostics Venture Capital
 HSMN NewsFeed - 19 Jul 2010
Abbott's PROGRESS Study of Kaletra and Isentress Compared with a Standard HIV Regimen Meets the Pre-Specified Primary Efficacy Endpoint
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 29 Jun 2010
Cardio3 BioSciences Reports Positive Three-Month Data From its Clinical Trial of C-Cure(R) in Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 21 Jun 2010
Toshiba's Aquilion ONE Improves Clinical Pathways for Emergency Departments
Devices Radiology
 HSMN NewsFeed - 26 May 2010
The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbott's Carotid Stent System and Surgery
Devices Interventional
 HSMN NewsFeed - 25 May 2010
Abbott's Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2010
Medtronic's Resolute(R) Drug-Eluting Stent Matches Market-Leading Rival in Large Head-to-Head Study
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2010
Abbott's Investigational MitraClip(R) System Demonstrates Strong Safety Results and Improved Clinical Outcomes for Common Causes of Leaky Heart Valves
Devices Cardiology
 HSMN NewsFeed - 25 May 2010
St. Jude Medical Enrolls First Patient in FAME II Clinical Trial to Study Use of Fractional Flow Reserve Technology in Patients With Stable Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2010
Boston Scientific Announces CE Mark and FDA Approval of NC Quantum Apex Balloon Catheter
Devices FDA Interventional Cardiology Regulatory
 HSMN NewsFeed - 17 May 2010
First Patient Treated in Aastrom's U.S. Phase 2 Catheter Clinical Trial in Dilated Cardiomyopathy
Regenerative Medicine Interventional Cardiology
 HSMN NewsFeed - 6 May 2010
The New England Journal of Medicine Publication of SPIRIT IV Trial Results Confirm Superior Safety and Efficacy of Abbott's XIENCE V(R) Drug Eluting Stent Compared to TAXUS
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Apr 2010
OSI Pharmaceuticals Announces That Tarceva(R) Received Approval in the European Union for Maintenance Use in Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 28 Apr 2010
Abbott Receives FDA Approval for Once-Daily Dosing of Kaletra(R) (lopinavir / ritonavir) for Treatment-Experienced Patients
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 27 Apr 2010
Physio-Control Launches Version 4.1 of Its LIFENET(R) System
Devices Monitoring
 HSMN NewsFeed - 27 Apr 2010
CRESTOR(TM) Gains New EU Indication to Prevent Major Cardiovascular Events in High Risk Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 14 Apr 2010
Bioheart Commenced Successful Regenerative Stem Cell Treatments with Latin American Patients Having Congestive Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 19 Mar 2010
OSI Pharmaceuticals Announces That Tarceva(R) Received a Positive Opinion from Health Authorities in the European Union for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 18 Mar 2010
Cameron Health Commences FDA-Approved IDE Clinical Trial of the Minimally Invasive Totally Subcutaneous Implantable Defibrillator for Treatment of Sudden Cardiac Arrest
Devices Cardiology
 HSMN NewsFeed - 16 Mar 2010
Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Mar 2010
Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the CYPHER(R) Sirolimus Drug-Eluting Stent over the Endeavor(R) Zotarolimus-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Mar 2010
Inadequate Response to Clopidogrel Leads to Higher Incidence of Major Adverse Cardiac Events in Patients Who have Undergone PCI
Biopharmaceuticals Diagnostics Cardiology
 HSMN NewsFeed - 15 Mar 2010
Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care
Devices Cardiology Monitoring
 HSMN NewsFeed - 15 Mar 2010
St. Jude Medical Announces Multiple Enhancements to Industry-Leading PressureWire FFR Measurement System
Devices Monitoring Cardiology
 HSMN NewsFeed - 26 Feb 2010
SCAI Statement on the CREST Study Findings: Carotid Stenting Is as Safe and Effective as Carotid Surgery in Patients at Risk for Stroke
Devices Interventional Neurology
 HSMN NewsFeed - 24 Feb 2010
GlaxoSmithKline Responds to US Senate Committee on Finance Report on Avandia
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 19 Feb 2010
In Honor of American Heart Month, TeleHealth Services and Local Hospitals Ask Patients to Watch More TV
Devices
 HSMN NewsFeed - 11 Feb 2010
Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 9 Feb 2010
Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter
Devices Interventional Cardiology Acquisitions
 HSMN NewsFeed - 4 Feb 2010
Bioheart Launches First US FDA Approved Clinical Trial that Tests Gene-Modified Stem Cell Therapy in Patients with Congestive Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 29 Jan 2010
Diffusion Pharmaceuticals LLC Closes on $5.9 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Jan 2010
Cardium Provides Update on Commercial Development Plans for Generx Angiogenic Therapy for Heart Disease at 2010 Cell & Gene Therapy Forum
Biopharmaceuticals Cardiology Regenerative Medicine
 HSMN NewsFeed - 15 Jan 2010
FDA Extends Review Period for Tarceva Application for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Jan 2010
deCODE Finds Genetic Factors Impacting Key Clinical Measurements of Heart Activity and Disease Risk
Diagnostics Cardiology
 HSMN NewsFeed - 5 Jan 2010
New Analysis Showed Effient(R) Cost-Effective Compared with Clopidogrel for Patients with Acute Coronary Syndromes Undergoing PCI
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 22 Dec 2009
Volcano Corporation Commends the Elevation of FFR to Level of Evidence A in New PCI Guidelines
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Dec 2009
Importance of FFR in Treatment of Coronary Artery Disease Confirmed by New PCI Guidelines
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Dec 2009
Medtronic Hires Renowned Cardiologist as Vice President of Medical Affairs for Coronary and Peripheral Business
Devices Cardiology Personnel
 HSMN NewsFeed - 1 Dec 2009
The Medicines Company Receives European Approval for Angiox(R) (Bivalirudin) for Use in Heart Attack Patients Undergoing Emergency Heart Procedures
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 20 Nov 2009
FDA Approves Intravenous Formulation Of Pfizer's Revatio(R) (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Nov 2009
AstraZeneca Submits US New Drug Application for Ticagrelor (BRILINTA(TM)), an Investigational Antiplatelet Agent
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 18 Nov 2009
New Updates to AHA/ACC/SCAI Clinical Guidelines Recommend Treatment with Effient(R) for Patients with Acute Coronary Syndromes Managed with PCI
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 17 Nov 2009
New Genomic Test for Coronary Artery Disease Now Available at The Heart & Vascular Center of Arizona
Diagnostics Cardiology
 HSMN NewsFeed - 17 Nov 2009
Genentech Submits Supplemental Applications to FDA for Avastin Combined with Commonly Used Chemotherapies for Women with Advanced Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 Nov 2009
OSI Pharmaceuticals Announces Tarceva to Be Reviewed by the FDA's Oncologic Drugs Advisory Committee for Use as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Oct 2009
FDA Approves New Use for Micardis(R) in Cardiovascular Risk Reduction and Twynsta(R) as New Combination Treatment for High Blood Pressure
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 16 Oct 2009
Clinical Center of Serbia, Institute for Cardiovascular Diseases Treats First Patient in Trial of Pioneering Stem Cell-Derived Therapy for Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 25 Sep 2009
Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents Compared to Bare-Metal Stents in Heart Attack Patients at Two Years
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Sep 2009
Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Sep 2009
Results from Abbott's PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease
Devices Cardiology
 HSMN NewsFeed - 24 Sep 2009
Ticagrelor Reduced Cardiovascular Deaths and Heart Attacks in ACS Patients Undergoing Heart Procedures: New Data from PLATO Trial
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 23 Sep 2009
FAME Trial Two-Year Follow-Up Results Demonstrate Continued Reduction in Risk of Death or Heart Attack When Physicians Use St. Jude Medical Fractional Flow Reserve Technology Prior to Implanting Coronary Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2009
Abbott's XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2009
TAXUS(R) Liberte(R) Stent Continues to Demonstrate Significant Improvements Over TAXUS(R) Express(R) Stent in Small Vessels and Long Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Sep 2009
Abbott Announces Approval in China for Next-Generation XIENCE V(R) Drug Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 1 Sep 2009
PreSCD II Registry Shows ICDs Lead to 44 Percent Reduction in Mortality for Heart Attack Survivors
Devices Cardiology
 HSMN NewsFeed - 31 Aug 2009
First Patient Enrolled in CYPRESS, a Dual Antiplatelet Therapy Trial with the CYPHER(R) Sirolimus-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Aug 2009
Abbott Launches Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in International Markets
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Aug 2009
New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of Plavix(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 24 Aug 2009
Health Canada Approves Abbott's XIENCE V(R) Drug Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 19 Aug 2009
Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
Biopharmaceuticals Onology
 HSMN NewsFeed - 5 Aug 2009
Merck and Schering-Plough Resolve Previously Disclosed Civil Class Action Lawsuits Related to VYTORIN(R) (ezetimibe/simvastatin) and ZETIA(R) (ezetimibe)
Biopharmaceuticals Cardiology Litigation
 HSMN NewsFeed - 1 Aug 2009
New Data from Phase III SATURN Study Showed Tarceva Extended Survival in Patients with Advanced Non-Small Cell Lung Cancer When Used Immediately after Initial Chemotherapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Jul 2009
Response Biomedical Receives U.S. FDA 510(k) Market Clearance of Rapid Respiratory Syncytial Virus Test
Diagnostics FDA
 HSMN NewsFeed - 21 Jul 2009
FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Jul 2009
New Data from Phase III SATURN Study Showed Tarceva Improved Overall Survival When Used Immediately After Initial Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Jul 2009
St. Francis Surgeon Uses Tissue Regeneration Technology to Rebuild Patients' Heart Structures
Devices Regenerative Medicine Cardiology
 HSMN NewsFeed - 17 Jun 2009
Xanodyne Receives Approval From the U.S. Food and Drug Administration for ZIPSOR(TM) (diclofenac potassium) Liquid Filled Capsules
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Jun 2009
Abbott Initiates Trial of Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Building Upon Superior Outcomes from SPIRIT Family of Trials
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Jun 2009
Cameron Health Announces CE Mark of the Minimally Invasive Totally Subcutaneous Implantable Defibrillator for Treatment of Sudden Cardiac Arrest
Devices Cardiology Regulatory
 HSMN NewsFeed - 12 Jun 2009
BARI 2D Study Presented at American Diabetes Association Scientific Sessions Underscores Utility of SPECT Myocardial Perfusion Imaging in Identifying Cardiovascular Risk and Evaluating Treatment Outcomes for Patients with Type 2 Diabetes
Biopharmaceuticals Radiology Cardiology
 HSMN NewsFeed - 11 Jun 2009
VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 9 Jun 2009
Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack
Biopharmaceuticals Endocrinology Cardiology
 HSMN NewsFeed - 8 Jun 2009
Inspire Medical Systems Completes $17 Million Series B Financing
Devices Venture Capital
 HSMN NewsFeed - 8 Jun 2009
Abbott's TRILIPIX(R) (Fenofibric Acid) in Combination With Rosuvastatin Calcium Helps Patients With Mixed Dyslipidemia and Type 2 Diabetes Meet American Diabetes Association Lipid Targets
Biopharmaceuticals Endocrinology Cardiology
 HSMN NewsFeed - 7 Jun 2009
SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Jun 2009
Abbott and AstraZeneca Extend Relationship to Include Co-Promotion of TRILIPIX(R) (fenofibric acid)
Biopharmaceuticals
 HSMN NewsFeed - 4 Jun 2009
Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD(TM), an Investigational Treatment for Mixed Dyslipidemia
Biopharmaceuticals
 HSMN NewsFeed - 1 Jun 2009
vProtect(TM) Luminal Shield Stabilizes Vulnerable Plaque
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Jun 2009
BioLineRx Announces Positive Preliminary Results From the Phase I/II Trial of BL-1040, the First Injectable Device Addressing Pathological Cardiac Remodeling
Devices Interventional Cardiology
 HSMN NewsFeed - 21 May 2009
Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 May 2009
Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2009
Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease
Devices Interventional
 HSMN NewsFeed - 19 May 2009
First Use in Coronary Patients of a Combined Near-Infrared Spectroscopy and Ultrasound Imaging Catheter
Devices Interventional Cardiology
 HSMN NewsFeed - 19 May 2009
NEVO Sirolimus-Eluting Coronary Stent Yields Superior Results to Taxus Liberte Stent in Pivotal Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 19 May 2009
Endeavor Drug-Eluting Stent is First to Receive CE Mark for Treating Acute Coronary Syndrome
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 14 May 2009
Control Medical Closes Series A Financing with Strategic Investors
Devices Surgery Venture Capital
 HSMN NewsFeed - 14 May 2009
New MADIT II Clinical Data Analysis Shows Long-Term Survival Benefit for Implantable Defibrillator Therapy
Devices Cardiology
 HSMN NewsFeed - 14 May 2009
Benefits of Catheter Ablation with the NAVISTAR THERMOCOOL Catheter Sustained for One Year in the Treatment of Symptomatic, Paroxysmal Atrial Fibrillation
Devices Cardiology
 HSMN NewsFeed - 11 May 2009
Schering-Plough Starts Patient Enrollment in Phase 3 Trial for Acadesine, an Investigational Agent Being Studied for Prevention of Complications From Cardiac Surgery
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 8 May 2009
New Data Shows Blood Pressure Reduction Therapy With BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure
Biopharmaceuticals
 HSMN NewsFeed - 6 May 2009
St. Jude Medical Announces FDA Clearance and Launch of the Attune Annuloplasty Ring for Heart Valve Repair
Devices Cardiology FDA
 HSMN NewsFeed - 5 May 2009
Merck Serono Launches Glucophage Powder in First European Countries
Biopharmaceuticals Endocrinology Regulatory
 HSMN NewsFeed - 4 May 2009
AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
Biopharmaceuticals
 HSMN NewsFeed - 22 Apr 2009
Lilly Granted Preliminary Injunction to Prevent Launch of Generic Raloxifene
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 21 Apr 2009
First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure
Devices Cardiology
 HSMN NewsFeed - 9 Apr 2009
New Clinical Data at ACC09 Show the CYPHER Sirolimus-eluting Coronary Stent Outperformed TAXUS LIBERTE and ENDEAVOR Stents in Key Outcome Measures
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Apr 2009
World-First Launch of New Heart Drug
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 7 Apr 2009
Aplenzin(TM), the Only Single Tablet Once-Daily Treatment for Depression at All Doses, Now Available in the United States
Biopharmaceuticals
 HSMN NewsFeed - 1 Apr 2009
Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease
Devices Interventional
 HSMN NewsFeed - 31 Mar 2009
Results from Medtronic-Supported Clinical Trial Assessing Use of Implantable Cardiac Devices in Certain Heart Attack Patients Show Reduction in Sudden Cardiac Death
Devices Cardiology
 HSMN NewsFeed - 31 Mar 2009
Cardium's InnerCool Announces Journal of Neurotrauma Highlights Hypothermia Therapy's Role in Post Cardiac Arrest, and Traumatic Brain and Spinal Cord Injury Patients
Devices Neurosurgery
 HSMN NewsFeed - 30 Mar 2009
FDA Approves Abiomed's New AB Portable Driver; Providing Patient Transport, Mobility and Ambulation without Compromising Performance
Devices FDA Cardiology
 HSMN NewsFeed - 29 Mar 2009
New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management
Biopharmaceuticals
 HSMN NewsFeed - 26 Mar 2009
Cordis Celebrates 50 Years of Transforming Cardiovascular Care
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Mar 2009
Ischemix Appoints Robert DuFresne as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2009
Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Mar 2009
Ardian Completes $47 Million Financing Led by Medtronic to Develop Hypertension Treatment
Devices Cardiology Venture Capital
 HSMN NewsFeed - 19 Mar 2009
OSI Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Tarceva as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Mar 2009
The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Mar 2009
Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 11 Mar 2009
Journal of the American College of Cardiology Publishes PROTECT I Study Results for Abiomed Impella 2.5
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Mar 2009
St. Jude Medical Announces European CE Mark Approval of Neurostimulation System for Chronic Angina
Devices Neurology Cardiology Regulatory
 HSMN NewsFeed - 10 Mar 2009
Abbott Launches VOYAGER(TM) NC Coronary Balloon Catheter
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Mar 2009
Lilly Granted Temporary Restraining Order to Halt Launch of Generic Raloxifene
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 5 Mar 2009
Abiomed Appoints Michael Howley as Vice President and General Manager of Global Sales and Marketing
Devices Cardiology Personnel
 HSMN NewsFeed - 5 Mar 2009
CYPHER Sirolimus-eluting Coronary Stent Demonstrates Sustained Benefits Compared to Bare-Metal Stents in Six-Year Randomized Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Mar 2009
Cambridge Heart's Non-Invasive Microvolt T-Wave Alternans Test Accurately Predicts Risk of Sudden Cardiac Arrest, Meta-Analysis Finds
Devices Cardiology Diagnostics
 HSMN NewsFeed - 26 Feb 2009
Inspire Medical Systems Completes First Implant of the Inspire II System to Treat Obstructive Sleep Apnea
Devices
 HSMN NewsFeed - 25 Feb 2009
Life-Saving TandemHeart from CardiacAssist Has Now Been Adopted by 100 of the Nation's Elite Cardiac Centers, Including All of the Top-10 as Ranked by U.S. News & World Report
Devices Cardiology
 HSMN NewsFeed - 23 Feb 2009
European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 19 Feb 2009
CRESTOR Cuts Risk of Stroke by Nearly Half in JUPITER Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 18 Feb 2009
New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Feb 2009
Newly Published Menopause Study: 'Bioidentical' and FDA-Approved Divigel(R) (estradiol gel) 0.1 Percent Safe and Effective Treatment for Moderate to Severe Hot Flashes Associated With Menopause
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 12 Feb 2009
Osiris Reports Positive Two-Year Data on Stem Cell Treatment for Acute Myocardial Infarction
Regenerative Medicine Cardiology
 HSMN NewsFeed - 11 Feb 2009
CYPHER SELECT(R) Plus Sirolimus-eluting Coronary Stent Now Approved in the European Union for Treatment of Patients With Diabetes
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 6 Feb 2009
deCODE Breakthrough in Thyroid Cancer May Enable More Targeted Risk Assessment and Earlier Intervention
Biopharmaceuticals Diagnostics Oncology
 HSMN NewsFeed - 6 Feb 2009
FDA Grants Marketing Approval to NAVISTAR(R) THERMOCOOL(R) Catheter for Atrial Fibrillation
Devices Cardiology FDA
 HSMN NewsFeed - 5 Feb 2009
Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Feb 2009
Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 2 Feb 2009
Medtronic Completes Enrollment in Global Head-to-Head Stent-Safety Study
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Jan 2009
Archemix Announces Continued Progress with Business Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jan 2009
New Research Suggests Platelet Stickiness May be the Single Most Important Risk Factor in Patients Treated with Coronary Stents - Findings May be Applicable to Anyone with Vascular Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Jan 2009
Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Jan 2009
BSD Medical: BSD-2000 Hyperthermia System Installed at Long Beach Memorial Medical Center
Devices Oncology
 HSMN NewsFeed - 19 Jan 2009
A Milestone in Cancer Genetics: deCODE Discovers First Common Genetic Variants Affecting the Risk of Many Types of Cancer
Biopharmaceuticals Diagnostics Oncology
 HSMN NewsFeed - 15 Jan 2009
vProtect(TM) Luminal Shield Stabilizes Life-Threatening Plaque
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Jan 2009
Kawasaki Disease Treated with Plasma-Derived Therapy
Biopharmaceuticals
 HSMN NewsFeed - 31 Dec 2008
FDA Cardio Renal Advisory Committee to Review Daiichi Sankyo, Lilly Drug Prasugrel
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 17 Dec 2008
Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Dec 2008
Bioheart, Inc. Announces Plans to Divest Non-Core Products to Increase Focus On Heart Failure Treatments
Devices Regenerative Medicine Cardiology
 HSMN NewsFeed - 15 Dec 2008
Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Dec 2008
Cardium's InnerCool Awarded U.S. Supplier Agreement With Novation LLC
Devices Group Purchasing
 HSMN NewsFeed - 9 Dec 2008
Portola Pharmaceuticals Initiates Phase II Trial of Novel IV and Oral Anti-Platelet Drug in Non-Urgent Percutaneous Coronary Intervention
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 5 Dec 2008
Osiris Receives Approval for Prochymal Expanded Access Program in Canada
Biopharmaceuticals Regenerative Medicine Regulatory
 HSMN NewsFeed - 19 Nov 2008
Cardio3 BioSciences receives its accreditation number from the Belgian Federal Agency for Medicines and Health Products for the manufacture of C-Cure(TM) for human use
Regenerative Medicine Cardiology
 HSMN NewsFeed - 11 Nov 2008
Study Finds Catheter Ablation with the NAVISTAR(R) THERMOCOOL(R) Catheter Superior to Anti-Arrhythmic Drug Therapy for the Treatment of Symptomatic, Paroxysmal Atrial Fibrillation
Devices Cardiology
 HSMN NewsFeed - 10 Nov 2008
FDA Approves Boston Scientific's Apex(TM) PTCA Dilatation Catheter
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 4 Nov 2008
Inverness Medical Innovations, PrognostiX Sign Distribution Agreement for CardioMPO(TM) Test
Diagnostics Cardiology Distribution
 HSMN NewsFeed - 3 Nov 2008
AtCor Medical Introduces New Portable Systems for Measuring Central Blood Pressure, Pulse Wave Velocity and Heart Rate Variability
Devices Monitoring
 HSMN NewsFeed - 27 Oct 2008
FDA Approves Duramed's LoSEASONIQUE(R) Oral Contraceptive
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Oct 2008
Cardium Announces FDA 510(K) Clearance of InnerCool's RapidBlue(TM) Endovascular System
Devices FDA
 HSMN NewsFeed - 17 Oct 2008
Pfizer Reaches Agreements in Principle to Resolve Litigation Involving Its NSAID Pain Medications
Biopharmaceuticals Litigation
 HSMN NewsFeed - 14 Oct 2008
Endeavor(R) Vs. Taxus(R): Medtronic's Drug-Eluting Coronary Stent Linked to Fewer Heart Attacks at Two Years Post Implant
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Oct 2008
Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Oct 2008
GE Healthcare and Boston Scientific Collaborate on Cardiovascular Imaging
Devices Cardiology Radiology
 HSMN NewsFeed - 13 Oct 2008
New Data Shows Abbott's Bioabsorbable Drug Eluting Stent is Absorbed Within Two Years - Leaving Behind Functioning Blood Vessels
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Oct 2008
deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Most Common Forms of Breast Cancer
Diagnostics Oncology
 HSMN NewsFeed - 3 Oct 2008
deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 30 Sep 2008
OrthoLogic Corp. Announces New Company Name: Capstone Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 30 Sep 2008
Bioheart Announces 35 Leading U.S. Heart Failure Centers Engaged in Phase II/III Marvel Trial of Myogenic Cells for Treating Advanced Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 11 Sep 2008
Cardiac Network Names Michael C. Swartzburg as Interim CEO
Devices Monitoring Cardiology Personnel
 HSMN NewsFeed - 9 Sep 2008
FDA Approves Testing to Explore Effectiveness of Rapid Patient Cooling in Traumatic Brain Injury Cases
Devices
 HSMN NewsFeed - 5 Sep 2008
Digirad Corporation Developing New Cardiac Imaging System With Distortion Correction
Devices Radiology Cardiology
 HSMN NewsFeed - 5 Sep 2008
Inverness Medical Launches Portable Blood Testing Monitor to Warn Patients and Their Physicians of Potential Blood Clots
Diagnostics
 HSMN NewsFeed - 4 Sep 2008
Clinical Data Indicate that Percutaneous Coronary Intervention with the CYPHER(R) Sirolimus-eluting Coronary Stent Is Comparable to Bypass Surgery in Key Safety Measures in Patients with Diabetes and Multi-Vessel Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Sep 2008
New Analysis From HORIZONS-AMI Shows Major Bleeding Has a Significant Impact and Contributes to 30-Day Mortality Following Angioplasty in Severe Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 3 Sep 2008
Stentys Appoints Rene Spaargaren, MD, as Chief Medical Officer
Devices Interventional Cardiology Personnel
Return to NewsFeed  

 Additional items found! 500

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 500 additional stories matching:
heart attack
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.